Table 4 Results for all patients during and after treatment
All Clari (n = 186)All Cipro (n = 185)All (n = 371)
MACM maloenseM xenopiAll 3 speciesMACM maloenseM xenopiAll 3 speciesTotal
No entered838617186878117185371
No deviated*29 (35%)21 (24%)10 (59%)60 (32%)37 (43%)35 (43%)8 (47%)80 (43%)140 (38%)
4th drug required (added)10 (10)3 (3)013 (13)15 (13)3 (2)1 (1)19 (16)32 (29)
Deaths from all causes40 (48%)36 (42%)5 (29%)81 (44%)26 (30%)45 (56%)8 (47%)79 (43%)160 (43%)
Deaths due to mycobacterial disease2406321612
Failures of treatment4 (1D)1 (1D)27 (2D)13411825 (2D)
Relapses73 (1D)212 (1D)7 (2D)007 (2D)19 (3D)
No completed treatment as allocated and alive and cured at 5 years20 (24%)33 (38%)3 (18%)56 (30%)20 (23%)16 (20%)2 (12%)38 (21%)94 (25%)
No alive and cured at 5 years26 (31%)42 (49%)6 (35%)74 (40%)30 (34%)25 (31%)6 (35%)61 (33%)135 (36%)
  • Clari, clarithromycin; Cipro, ciprofloxacilin; D, death due to mycobacterial disease; MAC, Mycobacterium avium intracellulare.

  • *Reasons for deviation are detailed in the second section of the Results.